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The simian retrovirus-1 constitutive transport element, unlike the
HIV-1 RRE, uses factors required for cellular mRNA export
Claudio Saavedra*, Barbara Felber† and Elisa Izaurralde*
Background: A hallmark of retroviral gene expression is that unspliced retroviral
genomic RNA is exported to the cytoplasm, whereas endogenous intron-
containing cellular RNAs are usually retained in the nucleus. In complex
retroviruses, such as human immunodeficiency virus-1 (HIV-1), nuclear export is
accomplished by the interaction of a virally encoded protein, Rev, with a cis-
acting RNA element, the Rev-responsive element (RRE). In type D retroviruses,
such as the simian retrovirus type 1 (SRV-1), however, genomic RNA is
exported by cellular factor(s) that interact with a conserved cis-acting RNA
element, the constitutive transport element (CTE). 
Results: We found that the CTE was exported in a specific and saturable
fashion from Xenopus oocyte nuclei. When inserted into the intron of an
adenovirus-derived pre-mRNA, the CTE did not affect splicing efficiency but
promoted the nuclear export of the excised intron lariat that is normally retained
within the nucleus. Export of CTE-containing RNAs to the cytoplasm was not
affected by the heterogeneous nuclear ribonucleoprotein A1 or an excess of
peptides corresponding to the Rev nuclear export signal. Microinjection of
saturating amounts of CTE RNA did not affect tRNA export or Rev-mediated
export but did inhibit mRNA export. CTE-mediated export was found to be
dependent on Ran-mediated GTP hydrolysis. 
Conclusion: The Rev–RRE system and the CTE direct intron-containing RNAs
to distinct export pathways. Although previous data have suggested that Rev
uses the same export pathway as uracil-rich small nuclear RNAs and 5S
ribosomal RNA, the CTE seems to interact with evolutionarily conserved factors
that are essential for cellular mRNA export. 
Background
RNA export from the nucleus is an energy-dependent
process that relies on recognition of the RNA or
ribonucleoprotein export substrates by saturable factors
[1–3]. Microinjection experiments in Xenopus oocytes have
revealed that different classes of RNA — transfer RNA
(tRNA), uracil-rich small nuclear RNA (UsnRNA), mes-
senger RNA (mRNA) and ribosomal RNA (rRNA) — do
not compete for export [3], indicating that their export is
mediated at least in part by specific factors [3–6]. These
factors are likely to be RNA-binding proteins that recog-
nise a common feature exhibited by RNA molecules of the
same class. Several cellular RNA-binding proteins have
been suggested to play a role in the export of different
classes of RNAs (reviewed in [7]) but, with the exception
of the nuclear cap-binding protein complex implicated in
the export of RNA polymerase II-transcribed spliceosomal
UsnRNAs [8], none of these RNA-binding proteins has
been shown to be directly involved in export.
Export of mRNAs has been suggested to be mediated by
heterogeneous nuclear ribonucleoproteins (hnRNPs;
reviewed in [9]). Of these, the best candidate is hnRNP
A1, which shuttles constantly between the nucleus and
cytoplasm [10]. Shuttling of hnRNP A1 is determined by a
38 amino-acid sequence, termed M9, located near the car-
boxyl terminus of the protein [11]; the M9 import receptor
has been identified as transportin [12,13]. Recently, it has
been shown that an excess of hnRNP A1 in the nucleus
saturates export of mRNA, providing evidence of a role for
this protein in mRNA export [14]. In order to prevent
translation of mRNAs into aberrant cellular proteins,
incompletely spliced mRNAs are retained in the nucleus
by binding to spliceosomal factors. The mature mRNA,
but not the excised intron, can be exported only after
splicing is completed [15]. 
To circumvent the requirement of splicing prior to export,
all retroviruses have evolved a mechanism that allows the
nuclear export of unspliced forms of viral RNAs, which are
essential for viral replication. In the case of complex retro-
viruses, a highly regulated mechanism has been identified.
This mechanism, best characterised in the human immun-
odeficiency virus type 1 (HIV-1), requires the activity of
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the virally encoded Rev protein and the presence of a Rev
response element (RRE) in the RNA [16–19]. The appear-
ance of intron-containing viral RNA in the cytoplasm is
directly promoted by the association between Rev and the
RRE. The complex is then exported by virtue of a leucine-
rich nuclear export signal (Rev-NES) present in the Rev
carboxy-terminal domain  [20,21]. Competition experi-
ments have shown that the Rev-NES promotes RNA
nuclear export by interacting with cellular factors that par-
ticipate in the export of two other classes of cellular RNAs:
UsnRNAs and 5S rRNA [4]. 
Simpler retroviruses, however, do not encode a Rev-like
trans-acting protein. In the case of the simian type D
retroviruses, Mason-Pfizer monkey virus (MPMV) and the
simian retroviruses type 1 and 2 (SRV-1 and SRV-2), a cis-
acting RNA element was recently demonstrated to act as
an autonomous export signal for unspliced mRNAs
[22–25]. This structured RNA element, termed the consti-
tutive transport element (CTE), shares structural and
functional similarities in all three type D retroviruses [23].
Furthermore, the CTEs from MPMV and SRV-1 can
functionally replace the Rev–RRE system in the context
of RNA export and HIV-1 virus replication [24,25], sug-
gesting that cellular factor(s) could play an analogous role
to that of Rev protein.
In this study, we report that the SRV-1 CTE, unlike the
HIV-1 Rev–RRE system, uses cellular factors that are
essential for the export of mRNAs. We propose that, after
overcoming nuclear retention, the CTE allows intron-
containing RNAs to access a late step in the mRNA
export pathway. 
Results 
The SRV-1 CTE promotes nuclear export of excised intron
lariats in Xenopus oocytes
The CTE has been proposed to interact with the cellular
transport machinery in order to bypass the retention mech-
anisms that normally confine pre-mRNAs to the nucleus
[22–26]. As a first step towards the identification of the
nuclear export pathway used by the CTE, we investigated
whether this element would promote the nuclear export of
intron-containing RNAs in Xenopus oocytes. A 173 bp
DNA fragment corresponding to the SRV-1 CTE was
cloned into the intron of an adenovirus-derived precursor
[27], which has previously been shown to be spliced effi-
ciently in Xenopus oocytes [28]. This insertion generated
two precursors that had the CTE inserted either in the
sense orientation, Ad-CTE, or the antisense orientation,
Ad-cte(as). Xenopus oocyte nuclei were injected with 32P-
radiolabelled RNAs synthesised in vitro using the original
adenovirus-derived construct (Ad), Ad-CTE or Ad-cte(as)
as templates. As an internal control for nuclear injection
and nuclear envelope integrity, we included radiolabelled
U6∆ss RNA in the injection mixtures: this RNA is not
exported from the nucleus and lacks the protein-binding
sites required for nuclear import, therefore remaining
localised at the site of injection [29,30]. After a 3 hour
incubation, oocytes were dissected and the nucleocyto-
plasmic distribution of the precursor RNA and the splicing
products was analysed. Figure 1 shows that whereas the
intron lariats derived from the splicing of Ad and Ad-
cte(as) templates were retained in the nucleus, the excised
intron lariat from Ad-CTE was exported to the cytoplasm
(Figure 1, compare lanes 4–6 and 16–18 with 10–12). In
contrast, the spliced mRNA product (Ad-mRNA), which is
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Figure 1
Excised intron lariats harbouring the SRV-1
CTE are exported to the cytoplasm in
Xenopus oocytes. Xenopus oocyte nuclei
were injected with a mixture of in vitro
transcribed 32P-labelled U6∆ss RNA and the
following precursor RNAs: Ad (lanes 1–6),
Ad-CTE (lanes 7–12) and Ad-cte(as) (lanes
13–18). The three precursors are derived
from the adenovirus major late transcription
unit. Ad-CTE and Ad-cte(as) contain the SRV-
1 CTE inserted in the sense and the antisense
orientation, respectively. U6∆ss does not
leave the nucleus and is an internal control for
nuclear integrity. Synthesis of precursor RNAs
was primed with the m7GpppG cap
dinucleotide, whereas synthesis of U6∆ss
RNA was primed with γ-mGTP. RNA samples
from total oocytes (T), cytoplasmic (C) and
nuclear (N) fractions were collected
immediately after injection (0 h) or 3 h after
injection as indicated. Products of the splicing
reaction were resolved on 10% acrylamide
7 M urea denaturing gels. The mature
products and intermediates of the splicing
reaction are indicated diagramatically on the
left of the panels. The filled triangle represents
the CTE.
T C
0 h
N T C
3 h
Ad
N T
U6∆ssU6∆ss
C
0 h
N T C
3 h
Ad-CTE
N T C
0 h
N T C
3 h
Ad-cte(as)
N
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
identical for the three precursors, was exported to the cyto-
plasm with the same efficiency irrespective of the pre-
mRNA from which it originated (Figure 1, lanes 4–6,
10–12, 16–18). The efficiency of splicing was similar for
the three precursor RNAs (Ad, Ad-CTE and Ad-cte(as);
lanes 4, 10 and 16, respectively) indicating that, in agree-
ment with a previous report [22], the CTE does not inter-
fere with spliceosome assembly. However, a small fraction
of the precursors remained unspliced after 3 hours incuba-
tion: this small fraction was exported to the cytoplasm in
all three cases, and therefore was probably not committed
to splicing and not retained in the nucleus. Although more
of the CTE-containing pre-mRNA was found in the cyto-
plasm, it is not clear that this difference is significant. 
Aside from the mature RNA, only the intron lariat har-
bouring the CTE is efficiently exported. This cis-acting
element is sufficient to bypass the mechanism that causes
nuclear retention of excised introns and to promote the
export of intron-containing RNAs into the cytoplasm. The
finding that the CTE functions in Xenopus oocytes indi-
cates that the cellular factors that recognise this element
are conserved from Xenopus to mammals. 
CTE-mediated export is saturable
As mentioned above, the CTE element is likely to
promote the export of intron-containing RNAs by inter-
acting with cellular factors. In order to test whether these
factors are limiting, radiolabelled Ad-CTE pre-mRNA
was co-injected into oocyte nuclei together with an excess
of unlabelled CTE RNA. The same amount of an RNA
corresponding to a CTE mutant (termed M37) that con-
tains a deletion of loop A and loop B was used as a nega-
tive control. The M37 mutant is defective in mediating
HIV-1 Gag production from an expression plasmid (C.
Tabernero and B.F. unpublished observations). In order
to avoid any possible competition for the nuclear cap-
binding complex that participates in both pre-mRNA pro-
cessing and export of RNA from the nucleus [8,31],
synthesis of the competitor RNAs was primed with the
cap analogue ApppG instead of m7GpppG. As shown in
Figure 2, injection of 0.1 picomoles of competitor CTE
RNA per oocyte nucleus abolished export of the CTE-
containing intron lariat (Figure 2, compare lanes 7–9 with
lanes 4–6), whereas co-injection of the same amount of
M37 RNA had no effect (Figure 2, lanes 10–12). In the
presence of the CTE competitor RNA, the production of
two degradation products derived from the intron lariat
and from the pre-mRNA was stimulated, suggesting that
the CTE-containing RNAs had become unstable
(Figure 2, bands indicated by asterisks; see also
Figures 4,5). The inhibitory effect of the CTE RNA was
independent of the cap structure (data not shown). 
Saturation of export of the intron lariat by the presence of
excess CTE RNA indicates that the CTE interacts with
an essential limiting factor while exporting the lariat.
Since the competitor RNA corresponds to the minimal
CTE (173 nucleotides) and does not share any other
common sequence with the precursor RNA, we conclude
that this element is sufficient to interact with the limiting
export factor(s), and that no additional RNA sequences are
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Figure 2
Saturation of the CTE nuclear export pathway.
A mixture of in vitro transcribed radiolabelled
Ad-CTE precursor RNA and U6∆ss RNA was
injected into Xenopus oocyte nuclei either
without competitor (lanes 1–6) or with
unlabelled competitor CTE RNA (lanes 7–9)
or unlabelled M37 competitor RNA (lanes
10–12). The M37 RNA is a mutant form of the
CTE lacking loops A and B. The amount of
competitor RNA injected per oocyte nucleus
was 0.1 pmol. Synthesis of competitor RNAs
was primed with the ApppG dinucleotide. In
lanes 1–3, RNA was extracted immediately
after injection, and in lanes 4–12, oocytes
were dissected 3 h after injection. RNAs were
analysed as described in Figure 1. Symbols
are as in Figure 1. The asterisks on the right of
the panel indicates the position of RNA
molecules that are likely to originate from the
degradation of the intron lariat and the
precursor RNA. These degraded RNAs are
also present in Figures 4,5.
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required for this activity. Note that the CTE competitor
RNA also interfered with the export of the mature mRNA
(Figure 2, compare lanes 7–9 with lanes 4–6). The
inhibitory effect of the CTE on the export of cellular RNAs
is discussed below. 
The CTE directs the excised intron lariat into an export
pathway distinct from that used by the HIV-1 Rev NES
Competition studies in Xenopus oocytes have shown that
the NES of Rev directs RRE-containing RNAs to an
export pathway that is used by two other species of cellu-
lar RNAs, the 5S rRNA and the UsnRNAs [4]. The obser-
vation that substitution of the RRE with either the
MPMV or the SRV-1 CTE bypasses the requirement of
Rev for HIV-1 and SIVmac expression and replication
[24–26,32] suggested that the CTE directs unspliced
RNAs to the same export pathway used by the Rev
protein. To test this hypothesis, CTE-mediated export
was analysed in the presence of Rev-NES peptides cross-
linked to bovine serum albumin, BSA (BSA–NES). As a
control, we used BSA conjugated to a peptide correspond-
ing to the inactive M10 mutant of the Rev-NES, generat-
ing BSA–M10 [33]. Xenopus oocyte nuclei were injected
with radiolabelled Ad-CTE pre-mRNA along with saturat-
ing amounts of BSA–NES or BSA–M10 (Figure 3a).
U1∆Sm RNA was included in the injection mixtures as a
control because export of this RNA has been shown to be
severely inhibited by BSA–NES peptide conjugates [4].
Splicing and export were analysed 3 hours after injection.
Surprisingly, saturation of the Rev-NES export pathway
did not affect the nuclear export of the excised intron
lariat bearing the CTE (Figure 3a, compare lanes 7–9 with
lanes 4–6), whereas export of U1∆Sm RNA was inhibited
under these conditions, as expected. Injection of
BSA–M10 had no effect on the export of any of the RNA
species analysed (Figure 3a, lanes 10–12). Thus, CTE-
mediated nuclear export is not saturated by BSA–NES
conjugates, suggesting that the CTE is likely to direct
RNAs to a pathway that is distinct from that used by HIV-
1 Rev, 5S rRNA and UsnRNAs. Consistent with this con-
clusion, we also observed that injection of up to
0.6 picomoles of U1∆Sm RNA per oocyte nucleus had no
effect on export of the CTE-containing intron lariat,
whereas it completely inhibited export of U5∆Sm RNA
(data not shown). 
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Figure 3
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(a) (b)
CTE promotes export of intron-containing RNAs by a distinct pathway
from the Rev–RRE system. (a) CTE-mediated nuclear export is not
inhibited by saturating amounts of Rev-NES peptides conjugated to
BSA. A mixture of in vitro transcribed 32P-labelled Ad-CTE precursor
RNA and U1∆Sm RNA was injected into Xenopus oocyte nuclei either
with (lanes 7–9) or without (lanes 1–6) BSA–NES competitor.
Competition with BSA–M10 is shown in lanes 10–12. The
concentration of the BSA–peptide conjugates in the injected samples
was 5 mg/ml and the final concentration in the oocyte nucleus was
5–10% of this value. In lanes 1–3, RNA was extracted immediately
after injection; in lanes 4–12, splicing and transport were analysed 3 h
after injection as described in Figure 1. (b) Rev-mediated export of
RRE-containing RNAs is not inhibited by saturating amounts of CTE
RNA. A mixture of 32P-labelled RNAs consisting of U6∆ss RNA and
Ad-CTE (lanes 1–9) or Ad-RRE (lanes 10–15) precursor RNAs was
injected into Xenopus oocyte nuclei. HIV-1 Rev protein was included in
the injection mixtures containing the Ad-RRE pre-mRNA. In lanes 1–6
and 10–12, the RNAs were injected in PBS. In lanes 7–9 and 13–15,
the injection mixture also contained unlabelled competitor CTE RNA.
The concentration of Rev protein in the injected samples was
2.5 pmol/µl. The amount of competitor RNA injected per oocyte
nucleus is indicated above the lanes. RNAs were extracted
immediately after injection in lanes 1–3 or after 3 h after injection in
lanes 4–15. The RRE is represented by an open triangle.
An alternative explanation for the results described above
is that the CTE might also interact with the export
machinery used by Rev–RRE, but with a much higher
affinity. If this were the case, the Rev-NES conjugates
would not compete efficiently in trans for CTE-mediated
export. In order to rule out this hypothesis, we injected an
excess of CTE RNA and analysed whether it could
compete for Rev-mediated export. Figure 3b shows that
Rev-mediated export of the RRE-containing intron lariat
was not affected by co-injection of up to 0.6 picomoles of
CTE RNA (Figure 3b, lanes 13–15). Note that 0.1 pico-
moles of CTE RNA per oocyte nucleus were sufficient to
completely saturate the export of the intron lariat contain-
ing the CTE (Figure 3b, lanes 7–9). Taken together,
these results indicate that the CTE signal drives the
export of intron-containing RNAs by a pathway different
from that used by the Rev–RRE system. 
CTE RNA interferes with the export of cellular mRNAs 
The experiments described above reveal that the CTE is
not using the export pathway used by HIV-1 Rev, 5S
rRNA and UsnRNAs. This result, together with the obser-
vation that microinjection of saturating amounts of CTE
competitor RNA inhibited the export of Ad-mRNA
(Figure 2, compare lanes 7–9 with the control lanes 4–6;
Figure 3b, compare lanes 7–9 with lanes 13–15), led us to
analyse whether the CTE export pathway has any
common features with the mRNA export pathway.
Xenopus oocyte nuclei were injected with a mixture of 32P-
labelled RNAs consisting of Ad-CTE pre-mRNA, mouse
dihydrofolate reductase (DHFR) mRNA, U1∆Sm, U6∆ss
and human initiator methionyl tRNA. Export of labelled
RNAs was analysed in the presence of increasing amounts
of unlabelled competitor CTE RNA. Mutant M37 RNA
was used as a negative control. Injection of 0.05 picomoles
of CTE RNA per oocyte inhibited the export of the CTE-
containing intron lariat (Figure 4, lanes 7–9). As shown in
Figure 2, however, injection of 0.1 picomoles of competi-
tor RNA was required to block lariat export completely
(Figure 4, lanes 10–12); under these conditions, export of
DHFR mRNA was severely inhibited. 
Complete inhibition of Ad-mRNA export required
higher concentrations of the competitor RNA (Figure 4,
lanes 16–18). The inhibitory effect of the CTE RNA on
export of DHFR and Ad-mRNAs was specific since the
M37 RNA had no effect at the highest concentration
used (Figure 4, lanes 19–21). Furthermore, the inhibition
was concentration-dependent, indicating that the CTE
competitor RNA was titrating a limiting factor required
Research Paper  CTE-mediated export in Xenopus oocytes Saavedra et al. 623
Figure 4
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CTE RNA interferes with mRNA nuclear export. Xenopus oocyte nuclei
were injected with a mixture of the following radioactively labelled
RNAs: Ad-CTE, DHFR mRNA, U1∆Sm, U6∆ss and human initiator
methionyl tRNA. In lanes 7–18, increasing amounts of unlabelled
competitor CTE RNA were included in the injection mixtures. The M37
RNA was used as a negative control (lanes 19–21). Synthesis of the
competitor RNAs and of labelled precursor Ad-CTE, DHFR mRNA and
U1∆Sm RNA was primed with the m7GpppG dinucleotide, whereas
synthesis of U6∆ss RNA was primed with γ-mGTP. In lanes 4–21,
RNA was extracted 3 h after injection, in lanes 1–3, RNA was
extracted immediately after injection. The concentration of the
competitor RNA injected per oocyte nucleus is indicated above the
lanes. The asterisks indicate the presence of the degraded RNAs.
for export of these mRNA species. Export of U1∆Sm
RNA and tRNA was not affected even when the concen-
tration of competitor was 8-fold higher than that required
to saturate export of the CTE-containing intron lariat
(Figure 4, lanes 16–18). Although the CTE RNA slightly
perturbed UsnRNA export in some experiments (data
not shown), this effect was not concentration-dependent
and thus was probably non-specific. As the kinetics of
tRNA export are much faster than those of mRNA and
UsnRNA export [3], we also analysed the effect of the
CTE competitor RNA 1 hour after injection. Even after
this short incubation, the export of tRNA was not
affected (data not shown). In conclusion, an excess of
CTE RNA specifically titrates a limiting factor(s)
required for the efficient export of DHFR mRNA and
Ad-mRNA. 
CTE-mediated export is not saturated by an excess of
hnRNP A1 protein
The competition experiment described above showed
that the CTE can block export of Ad and DHFR mRNAs
efficiently and specifically, and that the amount of
competitor required to obtain this effect was different for
each RNA. The different sensitivity of these RNAs to the
competition by CTE might imply either that Ad-mRNA
and DHFR mRNA export pathways use different limiting
factors or that they have different affinities for the same
binding factor. Note that different pre-mRNA and mRNA
transcripts have binding preferences for different hnRNP
proteins in vivo and in vitro [34,35]. DHFR mRNA export
has recently been demonstrated to be saturated by an
excess of hnRNP A1 [14]. We therefore examined
whether saturating amounts of hnRNP A1 could interfere
with CTE RNA export. In agreement with a previous
report [14], pre-injection of hnRNP A1 into oocyte nuclei
severely compromised export of DHFR mRNA (Figure 5,
lanes 7–9). In contrast, the export of Ad-mRNA, CTE
RNA and the CTE-containing lariat was unaffected. This
result suggests either that hnRNP A1 is not used by the
CTE for export or that hnRNP A1 is not the limiting
factor for CTE-mediated export. Consequently, the
finding that CTE saturates both Ad-mRNA and DHFR
mRNA nuclear export indicates that the CTE is accessing
a step in common with the export pathway of those RNAs:
this step must be downstream of the association between
hnRNP A1 and DHFR mRNA. 
CTE-mediated export is dependent on Ran GTPase activity
The results described above suggest that the CTE
allows intron-containing RNAs to access late steps in the
mRNA export pathway. As it has been suggested that
mRNA export depends on the small GTPase Ran
[36–40], we tested whether the export of CTE-contain-
ing RNA was also affected by perturbing Ran GTPase
activity. We used a mutant of Ran that contains a muta-
tion of the glutamine residue at position 69 to leucine
(RanQ69L [41]). This mutant has no GTPase activity
and should act as a dominant-negative inhibitor of
processes that require Ran-mediated GTP hydrolysis,
such as nuclear localisation signal-dependent nuclear
import [42,43].
A mixture of radiolabelled RNAs consisting of Ad-CTE
pre-mRNA, DHFR mRNA, U1∆Sm, U6∆ss and human
initiator methionyl tRNA was injected into oocyte nuclei
together with RanQ69L protein. Microinjection of this
protein into the nuclear compartment completely blocked
export of U1∆Sm RNA and severely inhibited the export
of most RNA species, including the excised intron lariat
containing the CTE (Figure 6, compare lanes 7–9 with
lanes 4–6). The export of tRNA was unaffected. The
inhibitory effect of RanQ69L was concentration-depen-
dent (Figure 6, compare lanes 7–9 with lanes 10–12).
Injection of RanQ69L into the oocyte nucleus did not
prevent protein import (data not shown), suggesting that
the export defects described above are direct and not a
secondary consequence of an import block. The export
inhibition by nuclear injection of RanQ69L suggests that
CTE-mediated export, like mRNA and UsnRNA export,
requires Ran-mediated GTP hydrolysis. 
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Figure 5
Injection of hnRNP A1 does not saturates CTE-mediated export.
Recombinant hnRNP A1 was injected into oocyte nuclei as indicated
above the lanes. After incubation for 1 h, a second microinjection was
performed into the oocyte nuclei with the same mixture of the
radioactively labelled RNAs described in Figure 4 including CTE RNA.
RNA was extracted 200 min after the second injection. The
concentration of the recombinant protein in the injected sample was
3 mg/ml. The asterisks indicate the presence of the degraded RNAs.
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Discussion
The constitutive transport element (CTE) from type D
retroviruses promotes the nuclear export of intron-contain-
ing RNAs by interacting with cellular factors (Figure 7). In
this report, we have shown that insertion of the SRV-1
CTE into the intron of a precursor mRNA promotes
export of the excised intron lariat following splicing in
Xenopus oocytes. This result suggests that there is conser-
vation of the cellular machinery used by the CTE to
bypass the retention mechanisms that usually confine
intron-containing RNAs to the nucleus.
Based on the observation that substitution of the HIV-1
RRE by the CTE allows viral replication in the absence
of Rev protein [24–26,32], it was plausible to speculate
that the CTE could direct intron-containing RNAs to the
same cellular pathway used by the HIV-1 Rev protein.
Surprisingly, however, our results demonstrated that the
CTE directs RNAs to an export pathway different from
that used by Rev. Firstly, RNAs bearing the CTE were
efficiently transported to the cytoplasm in the presence
of saturating amounts of a peptide comprising the Rev-
NES. Secondly, an excess of CTE RNA had no effect on
Rev-mediated export of an RRE-containing RNA. Fur-
thermore, a recent report has shown that a mutant form
of the Ran-binding protein 1 interferes with the
Rev–RRE pathway but not with the CTE pathway in
mammalian cells [44]. Taken together, these findings
demonstrate that the Rev–RRE and the CTE export
pathways are distinct.
This observation led us to examine whether the CTE was
exported from the nucleus via pathways used by other
classes of cellular RNAs. Our competition studies revealed
that, although saturating concentrations of the CTE RNA
inhibited export of mRNAs, they had only a minor effect
on the export of UsnRNAs and no effect on tRNA export.
The inhibitory effect of the CTE RNA on export of
mRNAs was specific and concentration-dependent. These
results suggest that the CTE is titrating a limiting factor
that is essential for mRNA export. 
Among the hnRNPs described to date, only hnRNP A1
has been directly implicated in mRNA nuclear export
[10–14]. An excess of recombinant hnRNP A1 protein has
been shown to inhibit export of DHFR mRNA [14]. In
agreement with this, when we co-injected hnRNP A1 into
oocyte nuclei together with a mixture of different classes
of RNAs, only DHFR mRNA was inhibited from exiting
the nucleus. Nuclear export of the CTE RNA was not
perturbed by high concentrations of hnRNP A1. In the
light of these observations, we speculate that the CTE
provides an export signal that bypasses one or more steps
of the mRNA nuclear transport process. One of these
steps would be the association of mRNA with hnRNP A1
and the recognition of this complex by a putative receptor.
Consequently, the observation that competitor CTE RNA
can also saturate Ad-mRNA export without being affected
by hnRNP A1 provides support for the existence of a
common late step in the mRNA export process that is
used by DHFR, spliced Ad-mRNAs and the CTE RNA.
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Figure 6
CTE-mediated export is dependent on the
small GTPase Ran. A mixture of radioactively-
labelled RNAs consisting of Ad-CTE, DHFR
mRNA, U1∆Sm, U6∆ss and human initiator
methionyl tRNA was injected into Xenopus
oocyte nuclei either with PBS (lanes 1–6) or
in the presence of mutant RanQ69L protein
(lanes 7–12). Dissection was performed 3 h
after injection (lanes 4–12), or immediately
after injection (lanes 1–3). RNA analysis was
performed as described in Figure 1. The
concentration of the recombinant protein in
the injection mixtures is indicated above the
lanes.
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One possible scenario is that the CTE avidly recruits
mRNA export factors to generate a export signal that has a
dominant effect over retention in the nucleus. Alterna-
tively, the CTE-binding factor(s) that allows nuclear
retention to be overcome does not interact with cellular
mRNAs; however, after overcoming retention and during
export to the cytoplasm, the CTE uses factors that are also
involved in cellular mRNA export. 
Finally, our results demonstrate that the small GTPase
Ran is required for CTE-mediated export. Ran acts in
concert with several factors that modulate its nucleotide-
bound state (reviewed in [45]). With a few exceptions,
almost all nucleocytoplasmic transport processes require
functional Ran [46], including CTE-mediated export as
shown here. It is interesting that both Rev–RRE-medi-
ated and CTE-mediated export differ in their pathways of
delivery of intron-containing RNAs to the cytoplasm. The
nature of this difference will be better understood when
the factors involved in these cellular pathways begin to be
fully identified. 
Conclusions
Cellular pre-mRNAs are normally retained in the nucleus.
After the removal of introns, the mRNA but not the intron
lariat is exported to the cytoplasm. In contrast to cellular
pre-mRNAs, unspliced retroviral RNAs are exported from
the nucleus by virtue of structured cis-acting elements (for
example, RRE and CTE). In the case of HIV-1, the RRE
interacts with the virally encoded protein Rev, which har-
bours a NES. Type D retroviruses do not encode a trans-
acting protein such as Rev, and the export of their
unspliced RNAs must therefore rely on the interaction of
the CTE with cellular factors. The Rev protein has been
previously shown to promote export by interacting with
factors that also participate in the export of UsnRNAs and
5S rRNA. In this study, we have demonstrated that the
CTE promotes export of intron-containing RNAs by a
pathway distinct from that used by the Rev–RRE system.
Furthermore, we have shown that the export of CTE
RNAs uses factors that are required for the export of cellu-
lar mRNAs, corroborating our finding that the CTE-medi-
ated export system is distinct from the Rev–RRE system.
Recently, similar results have been obtained using the
CTE from MPMV (A. Pasquinelli, E. Lund and J.
Dahlberg, personal communication).
Materials and methods
Materials
All enzymes used for DNA manipulations were purchased from New
England Biolabs. T7 or T3 RNA polymerases and RNasin were from
Promega. AmpliTaq DNA polymerase was from Perkin-Elmer Cetus. The
modified nucleotide γ-mGTP used to prime the synthesis of U6∆ss
RNA, and the cap analogue m7GpppG used to prime synthesis of all
precursor RNAs, DHFR mRNA, U1∆Sm were kind gifts of E.
Darzynkiewicz. The ApppG dinucleotide was purchased from
Boheringer. Labelled nucleoside triphosphates were from Amersham.
Isolation of plasmid DNA, cloning, transformation of Escherichia coli and
gel analysis of recombinant plasmids were performed as described [47].
PCR analysis was performed as described [48]. Synthesis of NES and
M10 peptides and coupling to BSA were performed as described [4].
The sequence (in single-letter amino-acid code) of the Rev-NES peptide
was CLPPLERLTL and that of the M10 mutant, CLPPDLRLTL. 
Plasmid constructions and synthesis of RNA in vitro
DNA templates for in vitro synthesis of DHFR mRNA, tRNA, U1∆Sm
and U6∆ss RNAs have been previously described [3]. Plasmids
p37S12 and Ad-RRE (pAd48) were described elsewhere [21,23]. To
obtain plasmids Ad-CTE and Ad-cte(as), a DNA fragment coding for
SRV-1 CTE was amplified by PCR using p37S12 as a template and
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Figure 7
Export of cellular mRNAs takes place after
removal of introns. In contrast with cellular
pre-mRNAs, unspliced viral RNAs are
exported by virtue of cis-acting elements (for
example, RRE and CTE). In the case of HIV-1,
the RRE interacts with the virally-encoded
protein Rev, which harbours a NES. Export of
unspliced viral RNA from Type D retroviruses
relies on the interaction of the CTE with
cellular factors: thus, unspliced CTE-
containing RNAs are constitutively exported.
As shown in these studies, the Rev–RRE
system and the CTE direct intron-containing
RNAs to distinct export pathways.
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primers 5′-GGTCCGCGGAGACCACCTCCCCTGCGA-3′ and
5′-CTCCCGCGGCAAATCCCTCGGAAGCTG-3′. The 173 bp PCR
product was digested with SacII and inserted in both orientations into
the unique SacII site of plasmid pBSAd1 [27]. The plasmid pBt-CTE
was constructed by excising a BamHI–XhoI DNA fragment from
p37S12 (containing the CTE) and inserting it into BamHI–XhoI
digested pBluescript KS+, thus placing the CTE downstream of the T7
promoter. The plasmid pBt-M37 carries a mutant form of the CTE that
has a deletion of loops A and B. For in vitro synthesis of radiolabelled
RNA, plasmids pBt-CTE and pBt-M37 were linearised with XhoI and
transcribed using T7 RNA polymerase, whereas plasmids pBS-Ad1,
pAd-CTE and pAd-cte(as) were linearised with Sau3A and transcribed
using T3 RNA polymerase. 
Xenopus oocyte microinjections and RNA analysis 
Oocyte injections and analysis of microinjected RNA by denaturing gel
electrophoresis and autoradiography analysis were performed as previ-
ously described [3]. The mutant RNAs used (U1∆Sm and U6∆ss) lack
the protein-binding sites required for the nuclear import of these RNAs
[30,49]. Thus U1∆Sm and U5∆Sm remain in the cytoplasm after export
from the nucleus. U6∆ss is neither exported nor imported and is used
as an internal control for nuclear injection and nuclear integrity. The
BSA–NES and BSA–M10 conjugates were injected at 5 µg/µl. The
concentrations of competitor RNAs in the injected samples are indi-
cated in the figure legends. 
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